How would you approach a T1N1 NSCLC with a small peripheral primary tumor and single hilar node in a patient not fit for concurrent chemo or surgery?

Would you offer SBRT to both sites, SBRT to the primary and standard fractionation to the node due to proximity to the main bronchus/proximal lobar bronchus? Would your recommendation change for a patient previously treated with SBRT for a peripheral tumor at least 2 years prior?

What about SCLC?

Answer from: Radiation Oncologist at Community Practice

If the patient were not a candidate for surgery or chemotherapy, then I would favor hypofractionated radiotherapy to 60 Gy in 15 fractions to both the primary and the hilar lymph node based on UTSW phase I data. If the patient may be a candidate for immunotherapy, then I would strongly consider enro...

Comments

Radiation Oncologist at Northeast Alabama Regional Medical Center
Assuming this is a T1N1 small cell lung cancer, wi...

Please select the option that best describes you:

How would you approach a T1N1 NSCLC with a small peripheral primary tumor and single hilar node in a patient not fit for concurrent chemo or surgery?

Related Questions